Bayer AG (BAYZF)
57.35
+1.18
(+2.09%)
USD |
OTCM |
Aug 25, 16:00
Bayer Shareholders Equity (Quarterly) : 33.82B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.82B |
| March 31, 2026 | 33.24B |
| December 31, 2025 | 30.47B |
| September 30, 2025 | 34.75B |
| June 30, 2025 | 35.65B |
| March 31, 2025 | 35.05B |
| December 31, 2024 | 33.04B |
| September 30, 2024 | 34.11B |
| June 30, 2024 | 38.25B |
| March 31, 2024 | 38.45B |
| December 31, 2023 | 36.37B |
| September 30, 2023 | 35.34B |
| June 30, 2023 | 40.31B |
| March 31, 2023 | 44.40B |
| December 31, 2022 | 41.38B |
| September 30, 2022 | 40.43B |
| June 30, 2022 | 39.75B |
| March 31, 2022 | 41.65B |
| December 31, 2021 | 37.55B |
| September 30, 2021 | 36.05B |
| June 30, 2021 | 36.04B |
| March 31, 2021 | 40.65B |
| December 31, 2020 | 37.35B |
| September 30, 2020 | 36.74B |
| June 30, 2020 | 40.10B |
| Date | Value |
|---|---|
| March 31, 2020 | 53.34B |
| December 31, 2019 | 53.04B |
| September 30, 2019 | 50.02B |
| June 30, 2019 | 50.90B |
| March 31, 2019 | 53.70B |
| December 31, 2018 | 52.56B |
| September 30, 2018 | 58.34B |
| June 30, 2018 | 55.04B |
| March 31, 2018 | 47.14B |
| December 31, 2017 | 44.19B |
| September 30, 2017 | 43.97B |
| June 30, 2017 | 37.24B |
| March 31, 2017 | 35.96B |
| December 31, 2016 | 31.99B |
| September 30, 2016 | 26.29B |
| June 30, 2016 | 25.24B |
| March 31, 2016 | 26.92B |
| December 31, 2015 | 26.36B |
| September 30, 2015 | 25.10B |
| June 30, 2015 | 24.89B |
| March 31, 2015 | 23.38B |
| December 31, 2014 | 24.33B |
| September 30, 2014 | 25.50B |
| June 30, 2014 | 26.63B |
| March 31, 2014 | 28.95B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck KGaA | 34.50B |
| Breakthrough Chemistry, Inc. | 0.8373M |
| Cardiac Biotech Solutions, Inc. | -2.221M |
| Fresenius SE & Co. KGaA | 22.52B |
| Carl Zeiss Meditec AG | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.66B |
| Total Liabilities (Quarterly) | 88.69B |
| Debt to Equity Ratio | 1.299 |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | -0.52% |